Revascularization System News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Revascularization System. Real-time updates on events, politics, business and more.

MIVI Neuroscience Presents Primary Endpoint Results from the EvaQ Trial — at the 2024 International Stroke Conference

February 9, 2024

Primary effectiveness endpoint results show high revascularization rates of 93.9% mTICI 2b/3

United States Bob Colloton Neuroscience Inc National Institutes Of Health Stroke Scale Clinical Events Committee International Stroke Conference

Source: dicardiology.com

Clinical Trial Enrollment Complete for Study of MIVI Q™ Revascularization System that Treats Acute Ischemic Stroke

May 3, 2023

/PRNewswire/ -- MIVI Neuroscience, Inc., innovator of next-generation neurointerventional medical devices, today announced that it has completed enrollment in...

United States Lucas Elijovich Bob Colloton Christophe Cognard Semmes Murphey Neurologic Institute In Memphis Drug Administration

Source: prnewswire.com

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science

Navigation

Revascularization System News Today

MIVI Neuroscience Presents Primary Endpoint Results from the EvaQ Trial &#x2014; at the 2024 International Stroke Conference

Clinical Trial Enrollment Complete for Study of MIVI Q&#x2122; Revascularization System that Treats Acute Ischemic Stroke

Explore More Categories

MIVI Neuroscience Presents Primary Endpoint Results from the EvaQ Trial — at the 2024 International Stroke Conference

Clinical Trial Enrollment Complete for Study of MIVI Q™ Revascularization System that Treats Acute Ischemic Stroke